In lung cancer, elevated levels of PAI-1 have been observed in tumor tissues compared to normal lung tissue, and this upregulation has been associated with advanced disease stages, poor prognosis, and reduced survival rates [29,30]. This evidence concerns the gene SERPINE1 and lung carcinoma.